Epigenetic and genetic regulation of PDCD1 gene in cancer immunology

Alok Mishra, Mukesh Verma

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Utilizing biology of PD-1: PD-L1 interaction related pathways for cancer immunotherapy is an emerging concept in cancer research. However, there is limited literature on epigenetic regulation of PD1 gene (PDCD1). Promising data from clinical trials of PD/PDl-1 immunotherapy in melanoma, renal cancers, colorectal and lung cancers has generated a lot of hope for successful treatment of patients. Immunotherapy in cancers has a significant role in strategizing NCI’s Cancer Moonshot Program of US NIH and FDA policies. The cost of the treatment by immunotherapy is extremely high. This preview presents a concise compilation of current knowledge on how the PD-1 gene is regulated in different cancers and infections. We have also discussed about epigenetic regulation of PDCD1 gene, especially the effect of different epigenetic inhibitors of DNA methylation and histone modifications at different steps in PD-1 regulation.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages247-254
Number of pages8
DOIs
StatePublished - Jan 1 2018

Publication series

NameMethods in Molecular Biology
Volume1856
ISSN (Print)1064-3745

Fingerprint

Neoplasm Genes
Allergy and Immunology
Epigenomics
Immunotherapy
Neoplasms
Lung Neoplasms
Histone Code
Genes
Kidney Neoplasms
DNA Methylation
Health Care Costs
Colorectal Neoplasms
Melanoma
Clinical Trials
Infection
Research

Keywords

  • Epigenetics
  • Immunotherapy
  • Oral cancer
  • PD/PDL-1 and immune check points

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Mishra, A., & Verma, M. (2018). Epigenetic and genetic regulation of PDCD1 gene in cancer immunology. In Methods in Molecular Biology (pp. 247-254). (Methods in Molecular Biology; Vol. 1856). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-8751-1_14

Epigenetic and genetic regulation of PDCD1 gene in cancer immunology. / Mishra, Alok; Verma, Mukesh.

Methods in Molecular Biology. Humana Press Inc., 2018. p. 247-254 (Methods in Molecular Biology; Vol. 1856).

Research output: Chapter in Book/Report/Conference proceedingChapter

Mishra, A & Verma, M 2018, Epigenetic and genetic regulation of PDCD1 gene in cancer immunology. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1856, Humana Press Inc., pp. 247-254. https://doi.org/10.1007/978-1-4939-8751-1_14
Mishra A, Verma M. Epigenetic and genetic regulation of PDCD1 gene in cancer immunology. In Methods in Molecular Biology. Humana Press Inc. 2018. p. 247-254. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-8751-1_14
Mishra, Alok ; Verma, Mukesh. / Epigenetic and genetic regulation of PDCD1 gene in cancer immunology. Methods in Molecular Biology. Humana Press Inc., 2018. pp. 247-254 (Methods in Molecular Biology).
@inbook{5e84115ea30f491682daecbe87ea5803,
title = "Epigenetic and genetic regulation of PDCD1 gene in cancer immunology",
abstract = "Utilizing biology of PD-1: PD-L1 interaction related pathways for cancer immunotherapy is an emerging concept in cancer research. However, there is limited literature on epigenetic regulation of PD1 gene (PDCD1). Promising data from clinical trials of PD/PDl-1 immunotherapy in melanoma, renal cancers, colorectal and lung cancers has generated a lot of hope for successful treatment of patients. Immunotherapy in cancers has a significant role in strategizing NCI’s Cancer Moonshot Program of US NIH and FDA policies. The cost of the treatment by immunotherapy is extremely high. This preview presents a concise compilation of current knowledge on how the PD-1 gene is regulated in different cancers and infections. We have also discussed about epigenetic regulation of PDCD1 gene, especially the effect of different epigenetic inhibitors of DNA methylation and histone modifications at different steps in PD-1 regulation.",
keywords = "Epigenetics, Immunotherapy, Oral cancer, PD/PDL-1 and immune check points",
author = "Alok Mishra and Mukesh Verma",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-8751-1_14",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "247--254",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Epigenetic and genetic regulation of PDCD1 gene in cancer immunology

AU - Mishra, Alok

AU - Verma, Mukesh

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Utilizing biology of PD-1: PD-L1 interaction related pathways for cancer immunotherapy is an emerging concept in cancer research. However, there is limited literature on epigenetic regulation of PD1 gene (PDCD1). Promising data from clinical trials of PD/PDl-1 immunotherapy in melanoma, renal cancers, colorectal and lung cancers has generated a lot of hope for successful treatment of patients. Immunotherapy in cancers has a significant role in strategizing NCI’s Cancer Moonshot Program of US NIH and FDA policies. The cost of the treatment by immunotherapy is extremely high. This preview presents a concise compilation of current knowledge on how the PD-1 gene is regulated in different cancers and infections. We have also discussed about epigenetic regulation of PDCD1 gene, especially the effect of different epigenetic inhibitors of DNA methylation and histone modifications at different steps in PD-1 regulation.

AB - Utilizing biology of PD-1: PD-L1 interaction related pathways for cancer immunotherapy is an emerging concept in cancer research. However, there is limited literature on epigenetic regulation of PD1 gene (PDCD1). Promising data from clinical trials of PD/PDl-1 immunotherapy in melanoma, renal cancers, colorectal and lung cancers has generated a lot of hope for successful treatment of patients. Immunotherapy in cancers has a significant role in strategizing NCI’s Cancer Moonshot Program of US NIH and FDA policies. The cost of the treatment by immunotherapy is extremely high. This preview presents a concise compilation of current knowledge on how the PD-1 gene is regulated in different cancers and infections. We have also discussed about epigenetic regulation of PDCD1 gene, especially the effect of different epigenetic inhibitors of DNA methylation and histone modifications at different steps in PD-1 regulation.

KW - Epigenetics

KW - Immunotherapy

KW - Oral cancer

KW - PD/PDL-1 and immune check points

UR - http://www.scopus.com/inward/record.url?scp=85052853131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052853131&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-8751-1_14

DO - 10.1007/978-1-4939-8751-1_14

M3 - Chapter

C2 - 30178256

AN - SCOPUS:85052853131

T3 - Methods in Molecular Biology

SP - 247

EP - 254

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -